Type 1 diabetes mellitus

Board exam relevance: in 5 of 105 exam reports · rank 69
Synonyms
type 1 diabetes, juvenile diabetes, insulin-dependent diabetes, T1D, LADA, autoimmune diabetes
Specialty
Internal medicine · Endocrinology & diabetes
Images
Clinical 1 · Histology 1
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (2)
  2. Definition
  3. Classification
  4. Occurrence & epidemiology
  5. Aetiopathogenesis
  6. Clinical features
  7. Diagnosis
  8. Keep learning in the app
  9. Further reading (open access)
  10. Cross-references

Images (2)

Type 1 diabetes mellitus – clinical photo: Necrobiosis lipoidica on the lower leg: yellowish atrophic plaques with a raised reddish-violaceous border
Necrobiosis lipoidica on the lower leg: yellowish atrophic plaques with a raised reddish-violaceous borderImage: Warfieldian (Wikimedia Commons) · CC BY-SA 3.0 · Source
Type 1 diabetes mellitus – Histology of necrobiosis lipoidica (H&E): layered granulomas and degenerated collagen throughout the dermisHistology
Histology of necrobiosis lipoidica (H&E): layered granulomas and degenerated collagen throughout the dermisImage: Nephron (Wikimedia Commons) · CC BY-SA 3.0 · Source
1 / 2

Definition

Type 1 diabetes mellitus is a chronic autoimmune disease in which the beta cells of the pancreatic islets of Langerhans are destroyed. The result is absolute insulin deficiency with chronic hyperglycemia. Type 1 accounts for about 5–10 % of all cases of diabetes.

A more slowly progressive autoimmune form in adults is called LADA (latent autoimmune diabetes in adults); because of its gradual onset it is often initially mistaken for type 2 diabetes.

Classification

Stages

  • Stage 1: at least two islet autoantibodies, normal plasma glucose, no symptoms.
  • Stage 2: impaired glucose tolerance or dysglycemia, still without symptoms.
  • Stage 3: clinically manifest diabetes with symptoms.

Occurrence & epidemiology

Type 1 diabetes usually begins in childhood or adolescence and is the most common form of diabetes diagnosed before the age of 20. It can, however, also develop in adulthood. Its frequency differs between populations; it is particularly high, for example, in people of Scandinavian or Sardinian ancestry.

Aetiopathogenesis

In genetically susceptible individuals, an environmental factor is thought to trigger a predominantly T-cell-mediated inflammation of the islets (insulitis) that progressively destroys the beta cells. This process runs unnoticed over months to years until the remaining beta-cell mass can no longer regulate plasma glucose. The glucagon-producing alpha cells are spared.

Genetics: the most important susceptibility genes lie in the HLA complex (MHC); the haplotypes DR3-DQ2.5 and DR4-DQ8 are found in more than 90 % of those affected who are younger than 30 years. Genes outside the MHC modify the risk further.

Autoantigens: the autoantigens include glutamic acid decarboxylase (GAD), insulinoma-associated protein 2 (IA-2), zinc transporter 8 (ZnT8) and proinsulin. The islet autoantibodies detectable in serum are regarded as a consequence rather than a cause of beta-cell destruction.

Environmental factors: viral infections have been linked to disease onset (particularly coxsackieviruses and SARS-CoV-2, as well as congenital cytomegalovirus and rubella infection). Viruses may damage beta cells directly or initiate an autoimmune reaction through molecular mimicry.

Type 1 diabetes occurs more often together with other autoimmune diseases, most commonly thyroid disease, celiac disease and pernicious anemia; less commonly Addison's disease, autoimmune liver disease and myasthenia gravis.

Clinical features

When plasma glucose rises above about 160–180 mg/dl (8.9–10.0 mmol/l), glycosuria with osmotic diuresis develops. Typical features are:

  • polyuria, urinary frequency and polydipsia
  • weight loss, sometimes with polyphagia
  • fatigue, weakness, blurred vision, nausea
  • dehydration up to orthostatic hypotension; altered mental status with severe dehydration
  • susceptibility to bacterial and fungal infections

In about one third of patients, diabetic ketoacidosis is the first manifestation. After onset, a prolonged phase of near-normal glucose levels may occur temporarily (honeymoon phase) because insulin secretion partially recovers.

Diagnosis

Diagnostic criteria

The criteria are valid for all forms of diabetes; with typical symptoms, one clearly elevated value is sufficient:

  • HbA1c ≥ 6.5 % (≥ 48 mmol/mol)
  • fasting plasma glucose ≥ 126 mg/dl (≥ 7.0 mmol/l)
  • 2-hour value in the oral glucose tolerance test (75 g) ≥ 200 mg/dl (≥ 11.1 mmol/l)
  • random plasma glucose ≥ 200 mg/dl (≥ 11.1 mmol/l) with symptoms of hyperglycemia

Classification as type 1

  • Islet autoantibodies: antibodies against GAD, IA-2, ZnT8 and islet cells, as well as IAA, prove the autoimmune origin; in relatives they precede clinical onset.
  • C-peptide: low levels indicate absent endogenous insulin secretion.
  • Clinical picture: young age and ketoacidosis at onset favor type 1, but age alone does not distinguish reliably.

Keep learning in the app

In the InnereFuchs app you can learn Type 1 diabetes mellitus with flashcards, exam questions and image tasks (ECG, chest X-ray, ultrasound, lab values) – free, in your browser or as an app.

Open in browser  About InnereFuchs →

Further reading (open access)

  1. MSD Manual Professional: Type 1 Diabetes Mellitus
  2. MSD Manual Professional: Overview of Diabetes Mellitus
  3. MSD Manual Professional: Acute Complications of Diabetes Mellitus

Cross-references

Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.